Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Estrogen and Interferon Alpha 2b for High-risk HPV
NCT05863975Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Jul 2023
- Primary completion
- Dec 2025
- Modality
- Cytokines & Interferons, Small Molecules
01
Overview
A Phase 4 trial of promestriene, Interferon alfa-2b vaginal effervescent tablet in human papillomavirus infection, sponsored by Shandong Provincial Qianfoshan Hospital. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
promestrieneInterferon alfa-2b vaginal effervescent tablet
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT05863975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05863975.